Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The hair follicle is composed of more than 20 kinds of cells, and mesoderm derived dermal papilla cells and keratinocytes cooperatively contribute hair growth via Wnt/β-catenin signaling pathway. We are to investigate β-catenin expression and regulatory mechanism by CBD in alopecia hair tissues and dermal papilla cells. Methods: We performed structural and anatomical analyses on alopecia patients derived hair tissues using microscopes. Pharmacological effect of CBD was evaluated by β-catenin expression using RT-PCR and immunostaining experiment. Results: Morphological deformation and loss of cell numbers in hair shaft were observed in alopecia hair tissues. IHC experiment showed that loss of β-catenin expression was shown in inner shaft of the alopecia hair tissues, indicating that β-catenin expression is a key regulatory function during alopecia progression. Consistently, β-catenin expression was decreased in testosterone or PMA treated dermal papilla cells, suggesting that those treatments are referred as a model on molecular mechanism of alopecia using dermal papilla cells. RT-PCR and immunostaining experiments showed that β-catenin expression was decreased in RNA level, as well as decreased β-catenin protein might be resulted from ubiquitination. However, CBD treatment has no changes in gene expression including β-catenin, but the decreased β-catenin expression by testosterone or PMA was restored by CBD pretreatment, suggesting that potential regulatory effect on alopecia induction of testosterone and PMA. Conclusion: CBD might have a modulating function on alopecia caused by hormonal or excess of signaling pathway, and be a promising application for on alopecia treatment.
Abstract
Objectives: The hair follicle is composed of more than 20 kinds of cells, and mesoderm derived dermal papilla cells and keratinocytes cooperatively contribute hair growth via Wnt/β-catenin signaling pathway. We are to investigate β-catenin expression and regulatory mechanism by CBD in alopecia hair tissues and dermal papilla cells. Methods: We performed structural and anatomical analyses on alopecia patients derived hair tissues using microscopes. Pharmacological effect of CBD was evaluated by β-catenin expression using RT-PCR and immunostaining experiment. Results: Morphological deformation and loss of cell numbers in hair shaft were observed in alopecia hair tissues. IHC experiment showed that loss of β-catenin expression was shown in inner shaft of the alopecia hair tissues, indicating that β-catenin expression is a key regulatory function during alopecia progression. Consistently, β-catenin expression was decreased in testosterone or PMA treated dermal papilla cells, suggesting that those treatments are referred as a model on molecular mechanism of alopecia using dermal papilla cells. RT-PCR and immunostaining experiments showed that β-catenin expression was decreased in RNA level, as well as decreased β-catenin protein might be resulted from ubiquitination. However, CBD treatment has no changes in gene expression including β-catenin, but the decreased β-catenin expression by testosterone or PMA was restored by CBD pretreatment, suggesting that potential regulatory effect on alopecia induction of testosterone and PMA. Conclusion: CBD might have a modulating function on alopecia caused by hormonal or excess of signaling pathway, and be a promising application for on alopecia treatment.
참고문헌 (38)
- Houschyar KS, "Molecular mechanisms of hair growth and regeneration : current understanding and novel paradigms", Dermatology, 236(4), pp.271~280 (2020)
- Premanand A, "Androgen modulation of Wnt", β-catenin signaling in androgenetic alopecia, 2018, pp.310(5), 391~399
- Davis BK, "Phases of the hair-growth cycle", Nature, 194, pp.694~ (1962)
- Iino M, "Adenosine stimulates fibroblast growth factor-7 gene expression via adenosine A2b receptor signaling in dermal papilla cells", J Invest Dermatol, 127(6), pp.1318~1325 (2007)
- Enshell-Seijffers D, "Betacatenin activity in the dermal papilla regulates morphogenesis and regeneration of hair", Dev Cell, 18(4), pp.633~642 (2010)
- Petiot A, "A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning", Development, 130(22), pp.5493~5501 (2003)
- Rosenquist TA, "Fibroblast growth factor signalling in the hair growth cycle : expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle", Dev Dyn, 205(4), pp.379~386 (1996)
- Schlake T, "FGF signals specifically regulate the structure of hair shaft medulla via IGF-binding protein 5", Development, 132(13), pp.2981~2990 (2005)
- Clevers H, "Wnt", β-catenin signaling and disease, 2012, pp.149(6), 1192~1205
- Nusse R, "Wnt", β-catenin signaling, disease, and emerging therapeutic modalities, 2017, pp.169(6), 985~999
- Breitkopf T, "The basic science of hair biology : what are the causal mechanisms for the disordered hair follicle", Dermatol Clin, 31(1), pp.1~19 (2013)
- Fischer TW, "Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro", Int J Dermatol, 46(1), pp.27~35 (2007)
- Berger RA, "Failure of topical testosterone in male-pattern alopecia", JAMA, 204(6), pp.451~452 (1968)
- Prager N, "A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia", J Altern Complement Med, 8(2), pp.143~152 (2002)
- Saad F, "Testosterone deficiency and testosterone treatment in older men", Gerontology, 63(2), pp.144~156 (2017)
- Nelson AM, "Bad hair day : testosterone and Wnts", J Invest Dermatol, 135(11), pp.2567~2569 (2015)
- Olsen EA, "The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss : results of a randomized placebo-controlled study of dutasteride versus finasteride", J Am Acad Dermatol, 55(6), pp.1014~1023 (2006)
- Jain R, "Potential targets in the discovery of new hair growth promoters for androgenic alopecia", Expert Opin Ther Targets, 18(7), pp.787~806 (2014)
- Kwack MH, "Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice", J Invest Dermatol, 132(1), pp.43~49 (2012)
- Rishikaysh P, "Signaling involved in hair follicle morphogenesis and development", Int J Mol Sci, 15(1), pp.1647~1670 (2014)
- Eicheler W, "Phorbol-myristateacetate, but not interleukin-1 beta or insulin-like growth factorI, regulates protein kinase C isoenzymes in human dermal papilla cells", Acta Derm Venereol, 77(5), pp.361~364 (1997)
- Ryan M, "Cannabidiol in epilepsy : the indications and beyond", Ment Health Clin, 10(6), pp.317~325 (2020)
- Silvestro S, "Use of cannabidiol in the treatment of epilepsy : efficacy and security in clinical trials", Molecules, 24(8), pp.1459~ (2019)
- Thomas A, "Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro", Br J Pharmacol, 150(5), pp.613~623 (2007)
- Parker LA, "Cannabidiol, a nonpsychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats", Neuroreport, 13(5), pp.567~570 (2002)
- Chagas MH, "Effects of cannabidiol in the treatment of patients with Parkinson’s disease : an exploratory double-blind trial", J Psychopharmacol, 28(11), pp.1088~1098 (2014)
- Szabó IL, "The phytocannabinoid(-)-cannabidiol operates as a complex, differential modulator of human hair growth : anti-inflammatory submicromolar versus hair growth inhibitory micromolar effects", J Invest Dermatol, 140(2), pp.484~488.e5 (2020)[DOI]
- Thom E, "Stress and the hair growth cycle : cortisol-induced hair growth disruption", J Drugs Dermatol, 15(8), pp.1001~1004 (2016)
- Kitagawa T, "Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal papilla cells", J Clin Endocrinol Metab, 94(4), pp.1288~1294 (2009)
- Lee SH, "Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells", PLoS One, 7(4), pp.e34152~ (2012)
- Huelsken J, "Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin", Cell, 105(4), pp.533~545 (2001)
- Goluch-Koniuszy ZS, "Nutrition of women with hair loss problem during the period of menopause", Prz Menopauzalny, 15(1), pp.56~61 (2016)
- Ekanayake-Mudiyanselage S, "Sebaceous glands as transporters of vitamin E", Hautarzt, 57(4), pp.291~296 (2006)[DOI]
- Bodó E, "A hot new twist to hair biology : involvement of vanilloid receptor-1(VR1", TRPV1)signaling in human hair growth control, 2005, pp.166(4), 985~998
- Borbíró I, "Activation of transient receptor potential vanilloid-3 inhibits human hair growth", J Invest Dermatol, 131(8), pp.1605~1614 (2011)
- Go YY, "Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma", Sci Rep, 10(1), pp.20622~ (2020)
- Massi P, "Cannabidiol as potential anticancer drug", Br J Clin Pharmacol, 75(2), pp.303~312 (2013)
- Seltzer ES, "Cannabidiol(CBD)as a promising anti-cancer drug", Cancers(Basel), 12(11), pp.3203~ (2020)